Literature DB >> 15997348

Midwall myocardial fibrosis in Becker-Kiener muscular dystrophy.

T Süselbeck1, D Haghi, W Neff, M Borggrefe, T Papavassiliu.   

Abstract

We report on a 38- year-old man with Becker-Kiener muscular dystrophy (BMD) and dilated cardiomyopathy without clinical symptoms of congestive heart failure who was referred for risk evaluation of sudden cardiac death. The degree of cardiac involvement in BMD varies greatly from no or hardly any cardiac abnormality to severe arrhythmias, dilatative cardiomyopathy and heart failure to heart transplantation or sudden cardiac death. These cardiac abnormalities have been related to replacement of the cardiomyocytes by connecting tissue or fat. In the clinical setting, cardiovascular magnetic resonance (CMR) has been proved to be a valid non-invasive method for obtaining anatomical and structural information of the heart. Furthermore, gadolinium-enhanced CMR can also characterize areas of myocardial fibrosis. Demonstration of extensive areas of fibrosis in an early stage of the disease might be a surrogate marker for an impaired clinical outcome. Therefore, serial CMR examinations starting upon diagnosis of the disease should be considered, as this may lead to an earlier recognition of cardiac involvement and may affect further management of the patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997348     DOI: 10.1007/s00392-005-0249-7

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  10 in total

1.  Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III.

Authors:  James C C Moon; Helen R Mundy; Philip J Lee; Raad H Mohiaddin; Dudley J Pennell
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

2.  Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy.

Authors:  A Varghese; D J Pennell
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

3.  [Cardio-MRT. The multimodal functional analysis of the future].

Authors:  G Horstick; S E Petersen; T Voigtländer; O K Mohrs; W G Schreiber
Journal:  Z Kardiol       Date:  2004

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

Authors:  C Basso; G Thiene; D Corrado; G Buja; P Melacini; A Nava
Journal:  Hum Pathol       Date:  2000-08       Impact factor: 3.466

Review 6.  The heart in human dystrophinopathies.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Cardiology       Date:  2003       Impact factor: 1.869

Review 7.  Dystrophies and heart disease.

Authors:  G F Cox; L M Kunkel
Journal:  Curr Opin Cardiol       Date:  1997-05       Impact factor: 2.161

8.  Assessment of left ventricular function with steady-state-free-precession magnetic resonance imaging. Reference values and a comparison to left ventriculography.

Authors:  O Grebe; H A Kestler; N Merkle; J Wöhrle; M Kochs; M Höher; V Hombach
Journal:  Z Kardiol       Date:  2004-09

9.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

10.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  Lubna Choudhury; Heiko Mahrholdt; Anja Wagner; Kelly M Choi; Michael D Elliott; Francis J Klocke; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094

  10 in total
  4 in total

1.  Patchy or homogenous myocardial fibrosis in Becker muscular dystrophy? Comments on Süselbeck et al., Z Kardiol 94:465-468/2005.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2006-04       Impact factor: 5.460

2.  Magnetic resonance imaging assessment of cardiac dysfunction in δ-sarcoglycan null mice.

Authors:  Janaka P Wansapura; Douglas P Millay; R Scott Dunn; Jeffery D Molkentin; D Woodrow Benson
Journal:  Neuromuscul Disord       Date:  2010-10-08       Impact factor: 4.296

Review 3.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

Review 4.  Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.

Authors:  Rita Wen Kaspar; Hugh D Allen; Federica Montanaro
Journal:  J Am Acad Nurse Pract       Date:  2009-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.